14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CTIC ranks #15555 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

CTI BioPharma Corp. Stock Forecast NASDAQ:CTIC

$2.67 (-1.48%)

Volume: 545k

Closed: Oct 22, 2021

Hollow Logo Score: -4.389

CTI BioPharma Corp. Stock Forecast

$2.67 (-1.48%)

Volume: 545k

Closed: Oct 22, 2021

Score Hollow Logo -4.389

CTI BioPharma Corp. Stock Price (Quote) NASDAQ:CTIC

$2.67 ( -1.48% ) Friday, 22nd Oct 2021

Range Low Price High Price Comment
30 days $2.62 $3.12 Friday, 22nd Oct 2021 CTIC stock ended at $2.67. This is 1.48% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 2.26% from a day low at $2.66 to a day high of $2.72.
90 days $2.35 $3.28
52 weeks $2.15 $4.13

Historical CTI BioPharma Corp. prices

Date Open High Low Close Volume
2021-10-22 $2.72 $2.72 $2.66 $2.67 545 324
2021-10-21 $2.75 $2.77 $2.71 $2.71 354 945
2021-10-20 $2.73 $2.77 $2.65 $2.75 825 168
2021-10-19 $2.72 $2.73 $2.69 $2.70 387 051
2021-10-18 $2.83 $2.84 $2.68 $2.72 765 728
2021-10-15 $2.65 $2.77 $2.63 $2.76 788 843
2021-10-14 $2.68 $2.71 $2.63 $2.65 333 288
2021-10-13 $2.66 $2.70 $2.62 $2.65 431 888
2021-10-12 $2.70 $2.78 $2.66 $2.67 527 502
2021-10-11 $2.68 $2.71 $2.65 $2.70 401 044
2021-10-08 $2.76 $2.78 $2.67 $2.68 498 513
2021-10-07 $2.82 $2.82 $2.68 $2.75 801 238
2021-10-06 $2.70 $2.72 $2.69 $2.71 576 349
2021-10-05 $2.79 $2.80 $2.71 $2.73 485 265
2021-10-04 $2.79 $2.81 $2.71 $2.76 1 175 289
2021-10-01 $3.07 $3.07 $2.86 $2.86 980 723
2021-09-30 $2.94 $2.99 $2.92 $2.95 488 930
2021-09-29 $3.00 $3.04 $2.90 $2.92 663 673
2021-09-28 $3.08 $3.08 $2.99 $3.00 630 121
2021-09-27 $3.03 $3.12 $3.03 $3.10 515 252
2021-09-24 $3.07 $3.07 $3.02 $3.04 453 588
2021-09-23 $3.08 $3.09 $3.04 $3.05 505 368
2021-09-22 $3.08 $3.08 $3.00 $3.05 589 133
2021-09-21 $3.05 $3.08 $3.00 $3.02 434 319
2021-09-20 $2.98 $3.04 $2.98 $3.01 655 783
2021-09-17 $3.02 $3.07 $2.99 $3.05 539 014
2021-09-16 $3.02 $3.05 $2.98 $3.03 579 030
2021-09-15 $3.03 $3.14 $3.02 $3.04 610 487
2021-09-14 $3.14 $3.17 $3.02 $3.03 746 289
2021-09-13 $3.17 $3.19 $3.12 $3.13 621 173
2021-09-10 $3.16 $3.22 $3.12 $3.18 814 528
2021-09-09 $3.09 $3.14 $3.06 $3.14 763 868
2021-09-08 $3.03 $3.06 $2.99 $3.06 1 061 686
2021-09-07 $3.20 $3.20 $3.01 $3.02 1 166 401
2021-09-03 $3.14 $3.15 $3.00 $3.09 1 238 876
2021-09-02 $3.27 $3.28 $3.05 $3.08 1 440 438
2021-09-01 $3.06 $3.15 $3.03 $3.15 1 100 382
2021-08-31 $3.00 $3.03 $2.98 $3.02 863 065
2021-08-30 $2.91 $3.02 $2.90 $2.96 1 573 110
2021-08-27 $2.83 $2.88 $2.83 $2.85 1 380 582
2021-08-26 $2.84 $2.85 $2.75 $2.82 1 387 462
2021-08-25 $2.84 $2.84 $2.75 $2.78 1 844 391
2021-08-24 $2.75 $2.75 $2.66 $2.74 699 872
2021-08-23 $2.71 $2.83 $2.66 $2.67 791 693
2021-08-20 $2.54 $2.75 $2.50 $2.60 1 651 062
2021-08-19 $2.62 $2.67 $2.54 $2.55 516 068
2021-08-18 $2.70 $2.70 $2.63 $2.64 624 538
2021-08-17 $2.64 $2.69 $2.62 $2.65 721 223
2021-08-16 $2.78 $2.78 $2.62 $2.64 904 084
2021-08-13 $2.80 $2.81 $2.69 $2.70 619 166

About CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also devel... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT